VYNE Therapeutics Inc (VYNE)
2.55
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
2.63
+0.08
(+3.14%)
After-Hours: 20:00
VYNE Therapeutics Free Cash Flow: -27.84M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -27.84M |
| December 31, 2023 | 198.59M |
| September 30, 2023 | 198.25M |
| June 30, 2023 | 198.59M |
| March 31, 2023 | -25.64M |
| December 31, 2022 | -29.20M |
| September 30, 2022 | -34.41M |
| June 30, 2022 | -44.82M |
| March 31, 2022 | -52.86M |
| December 31, 2021 | -56.37M |
| September 30, 2021 | -71.72M |
| June 30, 2021 | -77.82M |
| March 31, 2021 | -97.42M |
| Date | Value |
|---|---|
| December 31, 2020 | -137.20M |
| September 30, 2020 | -128.23M |
| June 30, 2020 | -120.98M |
| March 31, 2020 | -99.29M |
| December 31, 2019 | -65.11M |
| September 30, 2019 | -65.34M |
| June 30, 2019 | -61.25M |
| March 31, 2019 | -59.75M |
| December 31, 2018 | -52.87M |
| September 30, 2018 | -46.40M |
| June 30, 2018 | -46.65M |
| March 31, 2018 | -33.84M |
| December 31, 2017 | -28.22M |
Free Cash Flow Range, Past 5 Years
-137.20M
Minimum
Dec 2020
198.59M
Maximum
Jun 2023
-30.00M
Average
-58.81M
Median
Free Cash Flow Benchmarks
| Viking Therapeutics Inc | -54.87M |
| AN2 Therapeutics Inc | -59.28M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.982M |
| Cash from Investing (Quarterly) | -3.569M |
| Cash from Financing (Quarterly) | -0.004M |
| Free Cash Flow Per Share (Quarterly) | -0.1875 |
| Free Cash Flow to Equity (Quarterly) | -7.982M |
| Free Cash Flow to Firm (Quarterly) | -7.982M |
| Free Cash Flow Yield | -69.07% |